Large-scale testing (Phase 3)Study completedNCT00439725
What this trial is testing
Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study
Who this might be right for
Venous Thromboembolism
Bayer 1,197